首页>
外国专利>
TREATMENT OF HEPATITIS C IN THE ASIAN POPULATION OF BETA-INTERFERON SUBCUTE INTRODUCTION
TREATMENT OF HEPATITIS C IN THE ASIAN POPULATION OF BETA-INTERFERON SUBCUTE INTRODUCTION
展开▼
机译：亚洲人β-干扰素亚型人群中丙型肝炎的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The use of recombinant IFN-beta to obtain a drug for the treatment of HCV infection by subcutaneous administration to patients of the Asian race who do not respond to previous treatment with alpha interferon has been described. In a preferred embodiment of the invention, treatment may be more favorable and further focuses on those patients who, after 4 weeks of initial IFN-beta treatment, are characterized by HCV RNA clearance. The international application was published along with an international search report.
展开▼
